Aspartame and Risk of Cancer: A Meta-analytic Review

References

• Food and Drug Administration. Aspartame: commissioner's final decision. Docket no. 75F-0355. Fed Regist. 1981;46:38285–38308.
   Google Scholar
• European Food Safety Authority. Opinion of the Scientific Panel AFC related to a new long-term carcinogenicity study on aspartame. Available at: http://www.efsa.europa.eu/en/science/afc/afc_opinions/1471.html EFSA EU, afc_opinions, 1471 en. Published 2006. Accessed October 17, 2012.
   Google Scholar
• Fry J. The world market for intense sweeteners. World Rev Nutr Diet. 1999;85:201–211.
   PubMedGoogle Scholar
• Aspartame Information Center. Aspartame Information Center homepage. Available at: http://www.aspartame.org. Published 2005. Accessed November 27, 2012.
   Google Scholar
• Mead MN. Sour finding on popular sweetener: increases cancer incidence associated with low-dose aspartame intake. Environ Health Perspect. 2006;114:A176.
   PubMed Web of Science ®Google Scholar
• Huff J., Ladou L. Aspartame bioassay findings portend human cancer hazards. Int J Occup Environ Health. 2007;4:446–448.
   Google Scholar
• *Soffiriti M, Belpoggi F, Esposti DD, Lambertini L, Tibaldi E, Lauriola M. First carcinogenic effects of aspartame administered in the feed to Spague-Dawley rats. Environ Health Perspect. 2006;114:379–385.
   PubMed Web of Science ®Google Scholar
• Huff J. Long-term chemical carcinogenesis bioassays predict human cancer hazards issues, controversies, and uncertainties. Ann N Y Acad Sci. 1999;895:56–79.
   PubMed Web of Science ®Google Scholar
• *Ishii H, Koshimizu T, Usami S, Fujimoto T. Toxicity of aspartame and its diketopiperazine for Wistar rats by dietary administration for 104 weeks. Toxicology. 1981;21:91–94.
   PubMed Web of Science ®Google Scholar
• Hunty ADL, Gibson S, Ashwell M. A review of the effectiveness of aspartame in helping with weight control. Nutr Bull. 2006;31:115–128.
   Google Scholar
• Vartanian LR, Schwartz MB, Brownell KD. Effects of soft drink consumption on nutrition and health: a systematic review and meta-analysis. Am J Public Health. 2007;97:667–675.
   PubMed Web of Science ®Google Scholar
• Mattes RD, Shikany JM, Kaiser KA, Allison DB. Nutritively sweetened beverage consumption and body weight: a systematic review and meta-analysis of randomized experiments. Obes Rev. 2011;12:346–365.
   PubMed Web of Science ®Google Scholar
• Malik VS, Popkin BM, Bray GA, Despres JP, Willett WC, Hu FB. Sugar-sweetened beverages and risk of metabolic syndrome and type 2 diabetes: a meta-analysis. Diabetes Care. 2010;33:2477–2483.
   PubMed Web of Science ®Google Scholar
• Liberati A, Altman DG, Tetzlaff J, et al. The PRISMA statement for reporting systematic reviews and meta-analyses of studies that evaluate health care interventions: explanation and elaboration. Ann Intern Med. 2009;151(4):W65–94.
   PubMed Web of Science ®Google Scholar
• Rosenthal R. Meta-analytic Procedures for Social Research. Newbury Park, CA: Sage; 1991.
   Google Scholar
• Hunter JE, Schmidt FL. Methods of Meta-analysis: Correcting Error and Bias in Research Findings. Newbury Park, CA: Sage Publication; 1990.
   Google Scholar
• Sobin LH, Fleming ID, eds. TNM Classification of Malignant Tumors. Chicago, IL: Union International Control of Cancer and the American Joint Committee on Cancer. 1997; 80:1803–1804.
   Google Scholar
• Lipsey MW, Wilson DB. Practical Meta-analysis. Thousand Oaks, CA: Sage Publications; 2001.
   Google Scholar
• Cohen J. Statistical Power Analysis for the Behavioral Sciences. New York: Lawrence Erlbaum Associates; 1988.
   Google Scholar
• Borenstein M, Hedges LV, Higgins JPT, Rothstein H. Fixed-effect versus random-effects models. In: Introduction to Meta-analysis. Chichester, United Kingdom: John Wiley & Sons, Ltd.; 2009:77–85.
   Google Scholar
• Schmidt FL, Oh IS, Hayes TL. Fixed- versus random-effects models in meta-analysis: model properties and an empirical comparison of differences in results. Br J Math Stat Psychol. 2009;62:97–128.
   PubMed Web of Science ®Google Scholar
• Hedges LV. A random effects model for effect sizes. Psychol Bull. 1983;93:388–395.
   Web of Science ®Google Scholar
• Hedges LV, Olkin I, Statistiker M. Statistical Methods for Meta-analysis. New York: Academic Press; 1985.
   Google Scholar
• Higgins JPT, Thompson SG, Altman DG. Measuring inconsistency in meta-analyses. BMJ. 2003;327(7414):557–560.
   PubMed Web of Science ®Google Scholar
• Higgins JPT, Green S. Cochrane Handbook for Systematic Reviews of Interventions. Vol. 5. Chichester, UK: Wiley-Blackwell, 2008:278.
   Google Scholar
• Viechtbauer W. Bias and efficiency of meta-analytic variance estimators in the random-effects model. J Educ Behav Stat. 2005;30:261–293.
   Web of Science ®Google Scholar
• Borenstein M, Hedges L, Higgins J, Rothstein H. Comprehensive Meta-analysis, version 2.0 [computer software]. Englewood, NJ: Biostat; 2005
   Google Scholar
• Bax L, Yu LM, Ikeda N, Moons K. A systematic comparison of software dedicated to meta-analysis of causal studies. BMC Med Res Methods. 2007;7:40.
   PubMed Web of Science ®Google Scholar
• Council of Scientific Affairs. Aspartame: a review of safety issues. JAMA. 1985;254:400–402.
   PubMed Web of Science ®Google Scholar
• *File E-33. Appendix: Two Year Toxicity Study in the Rat. PT 838H71, submitted by G.D. Searle & Company to the FDA. Administrative Record, Aspartame. Docket No. 75F-0355, FDA, Rockville, Maryland, 1973.
   Google Scholar
• *File E-34. Two Year Toxicity Study in the Rat. PT 838H71, submitted by G.D. Searle & Company to the FDA. Administrative Record, Aspartame. Docket No. 75F-0355, FDA, Rockville, Maryland, 1973.
   Google Scholar
• *File E-70. Lifetime Toxicity Study in the Rat. PT 838H72, Final Report, submitted by G.D. Searle & Company to the FDA. Administrative Record, Aspartame. Docket No. 75F-0355, FDA, Rockville, Maryland, 1974.
   Google Scholar
• *File E-75. 104-Week Toxicity Study in the Mouse. PT 984H73, submitted by G.D. Searle & Company to the FDA. Administrative Record, Aspartame. Docket No. 75F-0355, FDA, Rockville, Maryland, 1974.
   Google Scholar
• Molinary SV. Preclinical studies of aspartame in nonprimate animals. In: Stegink LD, Filer LJ, eds. Aspartame Physiology and Biochemistry. New York: Dekker; 1984:289–306.
   Google Scholar
• *Ishii H. Incidence of brain tumors in rats fed aspartame. Toxicol Lett. 1981;7:433–437.
   PubMed Web of Science ®Google Scholar
• *National Toxicology Program (NTP). Toxicology Studies of Aspartame (CAS No. 22839–47–0) in Genetically Modified (FVB Tg.AC Hemizygous) and B6.129 Cdkn2atm1Rdp (N2) Deficient Mice and Carcinogenicity Studies of Aspartame in Genetically Modified [B6.129-Trp53tm1Brd (N5) Haploinsufficient] Mice (Feed Studies). Research Triangle Park, NC: US National Toxicology Program. NTP GMM1, NIH Publication No. 06–4459. Available at: http://ntp.niehs.nih.gov/files/GMM1-Web.pdf. Published 2005. Accessed October 11, 2012.
   Google Scholar
• *Soffiriti M, Belpoggi F, Tibaldi E, Esposti DD, Lauriola M. Lifespan exposure to low doses of aspartame beginning during prenatal life increases cancer effects in rats. Environ Health Perspect. 2007;115:1293–1297.
   PubMed Web of Science ®Google Scholar
• *Soffritti M, Belpoggi F, Manservigi M, et al. Aspartame Administered in Feed, Beginning prenatally through life span, induces cancers of the liver and lung in male Swiss mice. Am J Ind Med. 2010;52:1197–1206.
   Google Scholar
• Rosenthal R, Rubin DB. Comparing effect sizes of independent studies. Psychol Bull. 1982;92:500–504.
   Web of Science ®Google Scholar
• Fleiss JL. Measures of effect sizes for categorical data. In: Cooper H, Hedges LV, eds. The Handbook of Research Synthesis. New York: Russell Sage Foundation; 1994:245–260.
   Google Scholar
• Overton RC. A comparison of fixed-effects and mixed (random-effects) models for meta-analyses tests of moderator variable effects. Psychol Methods. 1998;3:354–379.
   Web of Science ®Google Scholar